Perclose wins approval for closure technique:
This article was originally published in Clinica
Executive Summary
The US FDA has approved Perclose's minimally-invasive system for the closure of arterial access sites following catheterisation procedures. The Prostar Systems were granted expedited review. Results of clinical trials submitted in support of the PMA application compared the Perclose systems, which are used in conjunction with anticoagulant and anti-platelet drug therapies, with conventional mechanical compression for site closure.
You may also be interested in...
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.